5-element Music Therapy on Patients With Breast Cancer

Guangzhou University of Traditional Chinese Medicine

Status

Completed

Conditions

Breast Cancer Female

Quality of Life

Depression, Anxiety

Treatments

Behavioral: 5-element music therapy

Study type

Interventional

Funder types

Other

Identifiers

NCT04442035

B2016-043-01

Details and patient eligibility

About

In this study, we observed the clinical effect of using music therapy of TCM to improve the status of liver depression in patients with postoperative breast cancer patients, Second we want to explore the efficacy and advantages of traditional Chinese medicine in patients with postoperative breast cancer, and to reveal the clinical use of the efficacy and superiority.

Full description

The study is a prospective controlled trial. Sixty-four patients were divided randomly into two groups. Patients were randomly divided into the treatment group and the control group, namely, the music treatment group and the health education group. The treatment group was given at least 30 minutes of individual music therapy and group music therapy every 3 weeks. Instead, the control group was given every 3 weeks of health education preach. It will take 12 weeks for treatment and observation. The efficacy was evaluated by observing the beginning and end of the trial of the Self-Rating Anxiety Scale score, the Self-Rating Depression Scale score, and the Breast Cancer Patients' Quality of Life Scale. At the end of the treatment, we take software packages SPSS 20.0 for management and statistical analysis.

Enrollment

64 patients

Sex

Female

Ages

27 to 66 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

the diagnosis of breast cancer in clinical stage (Ⅰ, Ⅱ, Ⅲ) and postoperative breast cancer during one month;
All participants had to have clinical depression and stagnation of liver qi;
age 27-66;
participants are conscious and willing to be followed up during the treatment.

Exclusion criteria

Metastasis of breast cancer or serious complications;
Patients with major depressive disorder;
The past medical history of mental disorders;
The primary diseases including liver, kidney, cerebrovascular, cardiovascular and hematopoietic system diseases;
Participating in another clinical study or undergoing another intervention;
Patients with hearing loss.